• Issues
    • Current Issue
    • Special Issues
  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • Hematologica Obscura
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Search
  • ASH Home
  • About ASH Clinical News
  • Authors
  • Advertising
  • Subscribe
  • Contact Us
  • eNewsletters
  • Cookie Settings
  • LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
  • Issues
    • AllCurrent IssueSpecial Issues

      March 2021 Special Edition

      March 2021 Volume 7 Issue 4

      February 2021 Volume 7 Issue 3

      Mid-January 2021 Annual Meeting Edition

  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • Hematologica Obscura
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Home Multimedia
  • Multimedia
  • Sound Bites

Let’s Get Cooking: Jonathan Hoggatt, PhD

Tuesday, October 16, 2018

In more from our interview with Dr. Hoggatt, he talks about the chocolate chip cookie experiment that started his obsession with cooking.

SHARE
ajones
Advertisement

Recent Articles

Novartis and the Gates Foundation Collaborate on Off-the-Shelf Gene Therapy for Sickle Cell Disease

Tuesday, March 2, 2021
Novartis and the Bill and Melinda Gates Foundation are collaborating on a one-step, one-time gene therapy for patients with sickle cell disease (SCD). The...

‘All of Us’ Technology Platform Aims to Democratize Research

Tuesday, March 2, 2021
All of Us, a $1.5 billion National Institutes of Health (NIH) initiative to collect DNA and health data on one million Americans from diverse...

FDA Accepts sNDA for Zanubrutinib in Waldenström Macroglobulinemia

Tuesday, March 2, 2021
The U.S. Food and Drug Administration (FDA) has accepted a supplemental new drug application (sNDA) for zanubrutinib for the treatment of adult patients with...

Crizotinib Approved for Relapsed/Refractory Systemic ALCL

Monday, March 1, 2021
Crizotinib has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of children older than one year and young adults...

Daratumumab and Hyaluronidase-fihj Approved for Light Chain Amyloidosis

Monday, March 1, 2021
The combination of daratumumab and hyaluronidase-fihj and bortezomib, cyclophosphamide, and dexamethasone (D-VCd) was granted accelerated approval for the treatment of adults with newly diagnosed...

Current Issue

March 2021 Volume 7 Issue 4

Monday, March 1, 2021
This issue examines the 21st Century Cures’ Act’s information blocking requirements, blood services around the globe, and more.
Related Articles
Recent Posts
  • Novartis and the Gates Foundation Collaborate on Off-the-Shelf Gene Therapy for Sickle Cell Disease
  • ‘All of Us’ Technology Platform Aims to Democratize Research
  • FDA Accepts sNDA for Zanubrutinib in Waldenström Macroglobulinemia
  • Crizotinib Approved for Relapsed/Refractory Systemic ALCL

Meeting Coverage

Researchers Validate Burkitt Lymphoma Prognostic Index

Monday, March 1, 2021

Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

Monday, March 1, 2021

Editor's Corner

Editor’s Corner: Healing Our Invisible Wounds

Monday, March 1, 2021

Editor’s Corner: A Period Piece

Monday, February 1, 2021
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
  • ASH Home
  • Research
  • Education
  • Advocacy
  • Meetings
  • Publications
  • ASH Store
Copyright © 2020 by American Society of Hematology

Contact Us | Terms of Service | Privacy Policy